Dyne Therapeutics Inc (DYN)

SG&A Expense Growth

20.93%

Quarterly · Period ending:

DYN logo

DYN SG&A Expense Growth

Latest reported20.93%
DYN Quarterly SG&A Growth (QoQ) (0.00% → 20.93%)
High-resolution chart · PNG

DYN sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dyne Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
20.9333%
17.823%
24.1408%
0.7128%
3.956%
4.0646%
19.0061%
32.5807%
-60.602%
178.3582%
25.947%
-7.6781%
-4.0616%
14.0063%
-8.6082%
24.922%
-19.2924%
-21.8656%
54.3958%
-0.588%
-3.3185%
0.1231%
69.2528%
186.428%
-23.9796%
45.6647%
87.1716%
39.5901%
0%
0%
43.1818%
4.7619%
5%
-9.0909%
7.3171%
5.1282%
5.4054%
8.8235%
17.2414%
-17.1429%
16.6667%
109.7403%
-1,332%
-13.7931%
11.5385%
-7.1429%
27.2727%
-12%
13.6364%
127.1605%
36.2205%
-388.6364%
91.3043%
-39.4737%
18.75%
28%
-37.5%
-24.5283%
3.9216%
3.1194%
143.7674%
22.6027%
-36.4486%
50.2326%
-321.5686%
59.8425%
2.3077%
-4%
-11.6071%
-180%
35.4839%
-29.1667%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.